Clinical Trial Update: Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial of bortezomib, dexamethasone, and cyclophosphamide for older patients with multiple myeloma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 2 | Status: WITHDRAWN